The Swiss drugmaker said it would pay Nurix $700 million upfront, while development costs would be split 60-40, with Roche taking the larger share.
Source link
Roche Enters $2.3 Billion Blood-Cancer Drug Deal With Nurix Therapeutics
Date:
More like thisRelated
SEC irked LSU is trying to dismiss suit with issue ‘unresolved’
Mark SchlabachSep 25, 2026, 07:38 PM ETCloseSenior college football...
Hurricane Nolo expected to bring heavy rain as it skirts Hawaii’s Big Island
Tess Kala, a South Point resident who grew up...
The White House has signaled that CNN will be left off Air Force One for President Donald Trump’s Saturday trip in the latest media...
CNN left off Air Force One for Trump's upcoming...
We All Hated Busy Work. Now That It’s Disappearing, It Turns Out We Miss It.
Restructurings and AI are making entry-level work more efficient....